Document is current

Article History

Accepted: 8 May 2022

First Online: 23 June 2022

Declarations

:

: No funding was received for the conduct of this research or the preparation of this article.

: The findings and conclusions expressed in this report are those of the authors and do not necessarily represent the views of the US FDA or the federal government.

: The authors declare no conflict of interest. Rave Harpaz, William DuMouchel, Robbert Van Manen, Alexander Nip, Steve Bright, and Magnus Lerch are employed by Oracle Health Sciences, which provides the signal detection and management software used to conduct the research for this article.

: Ethics approval was not needed for this study.

: Not applicable.

: Not applicable.

: The data used for this article are based on the public release of the Vaccine Adverse Event Reporting System (VAERS). The electronic supplementary material (ESM2) provides time-indexed disproportionality statistics for all the methodologies and AEs investigated in this study.

: Not applicable.

: All authors contributed to the writing, editing, and review of the manuscript and approved the final version for submission. All authors contributed to the analysis and interpretation of data. Conceptualization: RH and WD. Original draft: RH. Software and data resources: RM and AN.